DI IANNI, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 4.940
AS - Asia 3.422
EU - Europa 2.473
SA - Sud America 375
AF - Africa 60
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
Totale 11.283
Nazione #
US - Stati Uniti d'America 4.820
SG - Singapore 1.620
CN - Cina 882
IT - Italia 595
IE - Irlanda 360
RU - Federazione Russa 360
SE - Svezia 359
BR - Brasile 313
VN - Vietnam 309
TR - Turchia 281
UA - Ucraina 243
DE - Germania 162
GB - Regno Unito 117
HK - Hong Kong 68
BD - Bangladesh 61
FR - Francia 61
CA - Canada 57
IN - India 56
MX - Messico 46
NL - Olanda 37
FI - Finlandia 34
PL - Polonia 27
JP - Giappone 23
AR - Argentina 22
ES - Italia 21
ZA - Sudafrica 20
AT - Austria 16
BE - Belgio 16
IQ - Iraq 15
GR - Grecia 13
KR - Corea 12
PK - Pakistan 12
CO - Colombia 10
UZ - Uzbekistan 10
RO - Romania 9
VE - Venezuela 9
CH - Svizzera 8
EG - Egitto 8
ID - Indonesia 8
MA - Marocco 8
MY - Malesia 8
PH - Filippine 8
EC - Ecuador 7
CL - Cile 6
CZ - Repubblica Ceca 6
EU - Europa 6
SA - Arabia Saudita 6
AL - Albania 5
JM - Giamaica 5
JO - Giordania 5
KE - Kenya 5
LT - Lituania 5
TH - Thailandia 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
DZ - Algeria 4
HU - Ungheria 4
IL - Israele 4
IR - Iran 4
AU - Australia 3
BO - Bolivia 3
BW - Botswana 3
KZ - Kazakistan 3
NI - Nicaragua 3
NP - Nepal 3
PE - Perù 3
BG - Bulgaria 2
BY - Bielorussia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GD - Grenada 2
KH - Cambogia 2
OM - Oman 2
PT - Portogallo 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
BS - Bahamas 1
CG - Congo 1
CY - Cipro 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
NG - Nigeria 1
NO - Norvegia 1
NR - Nauru 1
NZ - Nuova Zelanda 1
PA - Panama 1
Totale 11.278
Città #
Singapore 1.253
San Jose 634
Chandler 550
Jacksonville 403
Ashburn 373
Dublin 356
Beijing 228
Dallas 192
Princeton 176
Los Angeles 170
Santa Clara 161
Izmir 153
Nanjing 139
Council Bluffs 121
Ho Chi Minh City 111
Altamura 93
Dearborn 89
The Dalles 80
Pescara 73
Cambridge 72
Hanoi 72
Boardman 70
Ann Arbor 68
Wilmington 64
Hong Kong 61
New York 59
Nanchang 56
Redondo Beach 39
Buffalo 38
Moscow 38
Chieti 37
São Paulo 37
Tongling 37
Woodbridge 36
Milan 35
Washington 33
Hefei 32
Hebei 29
Orem 27
Chicago 26
Rome 26
Mexico City 23
Warsaw 23
Kunming 22
Seattle 22
Brooklyn 21
Montreal 21
St Louis 21
Tianjin 21
Shenyang 20
Tokyo 20
Munich 19
Norwalk 19
San Francisco 19
Frankfurt am Main 17
Mumbai 17
Houston 16
Lappeenranta 16
Romola 16
Denver 15
Phoenix 15
Atlanta 14
Chennai 14
Jiaxing 14
London 14
Helsinki 13
Johannesburg 13
Nuremberg 13
Shanghai 13
Boston 12
Brussels 12
Dong Ket 12
Hangzhou 12
Manchester 12
Seoul 12
Haiphong 11
Rio de Janeiro 11
Amsterdam 10
Belo Horizonte 10
Stockholm 10
Toronto 10
Tashkent 9
Ascoli Piceno 8
Bologna 8
Da Nang 8
Istanbul 8
Kocaeli 8
Vienna 8
Biên Hòa 7
Changchun 7
Changsha 7
Dhaka 7
Ha Long 7
Hải Dương 7
Islamabad 7
Mordano 7
Naples 7
Can Tho 6
Düsseldorf 6
Jinan 6
Totale 7.110
Nome #
A novel, non-canonical splice variant of the Ikaros gene is aberrantly expressed in B-cell lymphoproliferative disorders. 183
CD19.CAR-T cell-derived extracellular vesicles express CAR and kill leukemic cells, contributing to antineoplastic therapy 180
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy 172
beta-galactosidase transduced T lymphocytes: a comparison between stimulation by either PHA and IL-2 or a mixed lymphocyte reaction. 148
NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications 148
B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor α 142
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 142
Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo 141
T lymphocyte transduction with herpes simplex virus-thymidine kinase (HSV-tk) gene: comparison of four different infection protocols. 140
Treg-protected donor lymphocyte infusions: a new tool to address the graft-versus-leukemia effect in the absence of graft-versus-host disease in patients relapsed after HSCT 138
Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation 133
"Designed" grafts for HLA-haploidentical stem cell transplantation 132
5-Azacytidine prevents transgene methylation in vivo 131
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation 131
NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion 127
Minimum information about T regulatory cells: A step toward reproducibility and standardization 127
A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 127
Primary eyelid plasmacytoma 126
Effect of trichostatin a and 5'-azacytidine on transgene reactivation in U937 transduced cells 125
The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma 125
To breathe or not to breathe: The haematopoietic stem/progenitor cells dilemma 124
Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation 124
G-CSF-induced thrombocytopenia in a healthy donor 122
Exploring the Immunomodulatory Potential of Pancreatic Cancer-Derived Extracellular Vesicles through Proteomic and Functional Analyses 121
Prognostic significance of genetic variants in the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation 119
The iron chelator deferasirox affects redox signalling in haematopoietic stem/progenitor cells 119
Clinical-Grade-Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell-Dependent Graft-versus-Leukemia Effect in Murine Models 119
MtDNA mutation associated with mitochondrial dysfunction in megakaryoblastic leukaemic cells 119
Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL 118
Secondary solid cancer following hematopoietic cell transplantation in patients with thalassemia major 118
Treating two concurrent B-cell and T-cell lymphoid neoplasms with alemtuzumab monotherapy 117
Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35 117
Myelofibrosis and allogeneic transplantation: critical points and challenges 116
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice 116
Comparison between adenoviral and retroviral vectors for the transduction of the thymidine kinase PET reporter gene in rat mesenchymal stem cells 116
T-lymphocyte function after retroviral-mediated thymidine kinase gene transfer and G418 selection 115
Retroviral transfer of herpes simplex virus-thymidine kinase and beta-galactosidase genes into U937 cells with bicistronic vector 115
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: Implications for cellular-based therapy 114
Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: The extended DACUS study 113
Interleukin 7-engineered stromal cells: A new approach for hastening naive T cell recruitment 113
Striking response to intrathecal liposomal cytarabine in a patient with meningeal myelomatosis [1] 112
T regulatory cell separation for clinical application 111
Retrovirus-mediated transfer of the herpes simplex virus thymidine kinase and enhanced green fluorescence protein genes in primary T lymphocytes 111
NOTCH and graft-versus-host disease 111
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 110
NeoR-based transduced T lymphocytes detected by real-time quantitative polymerase chain reaction 110
NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status 110
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation. 109
Tregs: Hype or hope for allogeneic hematopoietic stem cell transplantation? 109
Chronic myeloproliferative disorders: The bone marrow stromal component is not involved in the malignant clone [13] 109
Interleukin-7-Engineered Mesenchymal Cells: In Vitro Effects on Naive T-Cell Population 108
Next generation HLA-haploidentical HSCT 108
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 108
Unusual onset of venous thromboembolism and heparin-induced thrombocytopenia in a patient with essential thrombocythemia 107
Mesenchymal cells recruit and regulate T regulatory cells 106
Recurrent primary plasmacytoma of the eyelid with rapid regional metastasis 106
A novel NOTCH1 PEST domain mutation in a case of chronic lymphocytic leukemia 105
Hematopoietic stem/progenitor cells express myoglobin and neuroglobin: Adaptation to hypoxia or prevention from oxidative stress? 105
Evidence of jak2 val617phe positive essential thrombocythemia with splanchnic thrombosis during estroprogestinic treatment 105
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells 104
Transformation by retroviral vectors of bone marrow-derived mesenchymal cells induces mitochondria-dependent cAMP-sensitive reactive oxygen species production 104
Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome 104
NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models 104
Low Phosphatidylserine+ Cells Within the CD34+/CD45dim/CD117(c-kit)+ Subpopulation Are Associated with Poor Outcomes in Metastatic Colorectal Cancer 103
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 103
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation 103
Mesenchymal cells: A vehicle for gene therapy 102
Toxic epidermal necrolysis in a patient with primary myelofibrosis receiving thalidomide therapy 101
Graft engineering for allogeneic haploidentical stem cell transplantation 100
Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity 99
NOTCH1 aberrations in Chronic lymphocytic leukemia 99
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 99
NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL 98
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma 98
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin's lymphoma 98
Homing and survival of thymidine kinase-transduced human T cells in NOD/SCID mice 98
Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL 98
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option 97
A new genetic lesion in B-CLL: A NOTCH1 PEST domain mutation 97
Melphalan versus melphalan plus busulphan in conditioning to autologous stem cell transplantation for low-risk multiple myeloma 96
Immunomagnetic isolation of CD4+CD25+FoxP3 + natural T regulatory lymphocytes for clinical applications 96
Precision Medicine Approaches in Acute Myeloid Leukemia with Adverse Genetics 94
Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party 94
Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial 94
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation 93
Allogeneic stem cell transplantation in multiple myeloma: is there still a place? 92
NOTCH1 is aberrantly activated in chronic lymphocytic leukemia hematopoietic stem cells 92
Long‐term pharmacodynamic and clinical effects of twice‐ versus once‐daily low‐dose aspirin in essential thrombocythemia: The ARES trial 91
Loss of bone mineral density and secondary hyperparathyroidism are complications of autologous stem cell transplantation 91
In vivo demethylation of a MoMuLV retroviral vector expressing the herpes simplex thymidine kinase suicide gene by 5' azacytidine. 91
A microelectronic DNA chip detects the V617F JAK-2 mutation in myeloproliferative disorders [6] 90
Comparison between peripheral blood progenitor cell collection on the 4th or 5th day of granulocyte colony-stimulating factor treatment in allogeneic stem cell donors: implications for hematopoietic progenitor cell apheresis guidelines 88
Case Report: A case of pediatric persistent refractory ITP responsive to avatrombopag 87
Large-scale generation of human allodepleted anti-3rd party lymphocytes 82
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction 82
Novel Approaches to Treatment of Acute Myeloid Leukemia Relapse Post Allogeneic Stem Cell Transplantation 81
Case Report: Invasive fungal infection after anti-CD19 CAR-T cell therapy. Implication for antifungal prophylaxis 80
NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: De-novo origin? 79
Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation 79
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 78
Totale 11.092
Categoria #
all - tutte 47.057
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.057


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202194 0 0 0 0 0 0 0 0 0 0 0 94
2021/2022409 2 9 18 40 37 9 7 33 33 40 39 142
2022/20231.476 120 195 85 188 171 269 74 117 156 17 43 41
2023/2024698 54 23 60 29 67 155 153 36 22 45 10 44
2024/20252.302 121 542 502 86 44 79 102 122 182 80 243 199
2025/20264.569 386 227 437 432 468 305 855 285 461 365 269 79
Totale 12.001